Cargando…
Metabonomics adds a new dimension to fragile X syndrome
Fragile X syndrome is the most common cause of inherited intellectual disability, but the underlying pathophysiology is complex and effective treatments are lacking. In a recent study of fragile X mental retardation 1 (Fmr1) knockout mice, the metabolic profile of the fragile X brain was determined...
Autores principales: | Heulens, Inge, Braat, Sien, Kooy, R Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334545/ https://www.ncbi.nlm.nih.gov/pubmed/22204589 http://dx.doi.org/10.1186/gm296 |
Ejemplares similares
-
Involvement and Therapeutic Potential of the GABAergic System in the Fragile X Syndrome
por: Heulens, Inge, et al.
Publicado: (2010) -
Targeting fragile X
por: Gantois, Ilse, et al.
Publicado: (2002) -
Positron Emission Tomography (PET) Quantification of GABA(A) Receptors in the Brain of Fragile X Patients
por: D’Hulst, Charlotte, et al.
Publicado: (2015) -
Mouse models of fragile X-related disorders
por: Willemsen, Rob, et al.
Publicado: (2023) -
Open-label add-on treatment trial of minocycline in fragile X syndrome
por: Paribello, Carlo, et al.
Publicado: (2010)